Anindita Roy

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome.

The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome.

Journal: Leukemia
Published: February 17, 2026

The fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemia.

The fetal specific gene LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemia.

Journal: Blood
Published: May 05, 2025

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Journal: Blood
Published: March 21, 2025

comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders.

comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders.

Journal: Cell stem cell
Published: March 03, 2025

Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.

Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.

Journal: Blood
Published: December 13, 2024

PROM1/CD133 marks a proliferative stem cell-like population of blasts in KMT2A rearranged infant ALL.

PROM1/CD133 marks a proliferative stem cell-like population of blasts in KMT2A rearranged infant ALL.

Journal: Blood advances
Published: October 29, 2024

Aberrant stem cell and developmental programs in pediatric leukemia.

Aberrant stem cell and developmental programs in pediatric leukemia.

Journal: Frontiers in cell and developmental biology
Published: January 18, 2024

Backtracking to the future: unraveling the origins of childhood leukemia.

Backtracking to the future: unraveling the origins of childhood leukemia.

Journal: Leukemia
Published: October 05, 2023

A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.

A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.

Journal: Blood
Published: April 18, 2023

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.

MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.

Journal: Nature communications
Published: December 08, 2022

Processing single-cell RNA-seq datasets using SingCellaR.

Processing single-cell RNA-seq datasets using SingCellaR.

Journal: STAR protocols
Published: April 08, 2022

Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies.

Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies.

Journal: Cancer discovery
Published: February 21, 2022
Showing 1-12 of 42

Last Updated: 09/26/2026